|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States. |
| 公司地址
| 7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237 |
| 電話號碼
| +1 720 437-6580 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.aytubio.com |
| 員工數量
| 76 |
| Mr. Joshua R. Disbrow |
Director and Chief Executive Officer |
美元 608.15K |
22/10/2026 |
| Mr. Jarrett T. Disbrow |
Chief Business Officer |
美元 398.14K |
22/10/2026 |
| Mr. Ryan J. Selhorn |
Chief Financial Officer, Principal Accounting Officer, Corporate Secretary and Treasurer |
美元 432.46K |
22/10/2026 |
| Mr. Greg Pyszczymuka |
Chief Commercial Officer |
美元 434.30K |
22/10/2026 |
|
|
| Ms. Vivian H. Liu |
Independent Director |
22/10/2026 |
| Mr. Joshua R. Disbrow |
Director and Chief Executive Officer |
22/10/2026 |
| Mr. Carl C. Dockery |
Independent Director |
22/10/2026 |
| Mr. John A. Donofrio, Jr |
Chairman of the Board |
22/10/2026 |
| Mr. Abhinav Jain |
Independent Director |
22/10/2026 |
|
|
|
|